Alton EW - Search Results

1

Validation of nasal potential difference measurements in gut-corrected CF knockout mice.

Griesenbach U, Smith SN, Farley R, Singh C, Alton EW. Griesenbach U, et al. Among authors: alton ew. Am J Respir Cell Mol Biol. 2008 Oct;39(4):490-6. doi: 10.1165/rcmb.2007-0385OC. Epub 2008 May 5. Am J Respir Cell Mol Biol. 2008. PMID: 18458238

2

The prospects for gene therapy in cystic fibrosis.

Alton E, Geddes D. Alton E, et al. Curr Opin Pulm Med. 1995 Nov;1(6):471-7. doi: 10.1097/00063198-199511000-00007. Curr Opin Pulm Med. 1995. PMID: 9363084 Review.

3

Effects of altering dosing on cationic liposome-mediated gene transfer to the respiratory epithelium.

Hillery E, Cheng S, Geddes D, Alton E. Hillery E, et al. Gene Ther. 1999 Jul;6(7):1313-6. doi: 10.1038/sj.gt.3300953. Gene Ther. 1999. PMID: 10455441

4

The pathogenesis of cystic fibrosis and progress towards gene therapy.

Stern M, Alton E. Stern M, et al. J R Coll Physicians Lond. 1999 Sep-Oct;33(5):434-9. J R Coll Physicians Lond. 1999. PMID: 10624657 Review. No abstract available.

5

Pretreatment with cationic lipid-mediated transfer of the Na+K+-ATPase pump in a mouse model in vivo augments resolution of high permeability pulmonary oedema.

Stern M, Ulrich K, Robinson C, Copeland J, Griesenbach U, Masse C, Cheng S, Munkonge F, Geddes D, Berthiaume Y, Alton E. Stern M, et al. Gene Ther. 2000 Jun;7(11):960-6. doi: 10.1038/sj.gt.3301193. Gene Ther. 2000. PMID: 10849556

6

Measure and interpretation of CF gene therapy trial results.

Alton E, Geddes D, Gill D, Greening A, Higgins C, Hyde S, Innes JA, Porteous D, Stern M. Alton E, et al. Mol Ther. 2000 Jul;2(1):3-4. doi: 10.1006/mthe.2000.0097. Mol Ther. 2000. PMID: 10899820 Free article. No abstract available.

7

Gene therapy for cystic fibrosis.

Alton E, Kitson C. Alton E, et al. Expert Opin Investig Drugs. 2000 Jul;9(7):1523-35. doi: 10.1517/13543784.9.7.1523. Expert Opin Investig Drugs. 2000. PMID: 11060757 Review.

8

The severe G480C cystic fibrosis mutation, when replicated in the mouse, demonstrates mistrafficking, normal survival and organ-specific bioelectrics.

Dickinson P, Smith SN, Webb S, Kilanowski FM, Campbell IJ, Taylor MS, Porteous DJ, Willemsen R, de Jonge HR, Farley R, Alton EW, Dorin JR. Dickinson P, et al. Among authors: alton ew. Hum Mol Genet. 2002 Feb 1;11(3):243-51. doi: 10.1093/hmg/11.3.243. Hum Mol Genet. 2002. PMID: 11823443 Free article.

9

The nasal epithelium as a factory for systemic protein delivery.

Griesenbach U, Cassady RL, Ferrari S, Fukumura M, Müller C, Schmitt E, Zhu J, Jeffery PK, Nagai Y, Geddes DM, Hasegawa M, Alton EW. Griesenbach U, et al. Among authors: alton ew. Mol Ther. 2002 Feb;5(2):98-103. doi: 10.1006/mthe.2002.0524. Mol Ther. 2002. PMID: 11829516 Free article.

10

Gene complementation of airway epithelium in the cystic fibrosis mouse is necessary and sufficient to correct the pathogen clearance and inflammatory abnormalities.

Oceandy D, McMorran BJ, Smith SN, Schreiber R, Kunzelmann K, Alton EW, Hume DA, Wainwright BJ. Oceandy D, et al. Among authors: alton ew. Hum Mol Genet. 2002 May 1;11(9):1059-67. doi: 10.1093/hmg/11.9.1059. Hum Mol Genet. 2002. PMID: 11978765

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results